| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/18/2007 | EP1773341A1 Piperazine derivatives for the treatment of female sexual disorders |
| 04/18/2007 | EP1773340A2 Pharmaceutical composition of (+)-erythro-mefloquine and its use in the treatment of an inflammatory condition |
| 04/18/2007 | EP1773339A2 Crystalline form of donepezil hydrochloride |
| 04/18/2007 | EP1773338A2 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 04/18/2007 | EP1773337A2 Modulators of nuclear receptors |
| 04/18/2007 | EP1773336A1 Use of a steroid for enhancement of skin permeability |
| 04/18/2007 | EP1773335A2 Nanoparticle dispersion containing lactam compound |
| 04/18/2007 | EP1773334A1 Epothilone combinations |
| 04/18/2007 | EP1773333A1 Composition for the prevention and treatment of allergic inflammatory disease |
| 04/18/2007 | EP1773332A1 Pharmaceutical composition for the treatment of bone fracture |
| 04/18/2007 | EP1773331A1 Imidazole and thiazole derivatives as antiviral agents |
| 04/18/2007 | EP1773330A2 Substituted pyrazoles, compositions containing such compounds and methods of use |
| 04/18/2007 | EP1773329A1 Compositions and methods for treatment of colitis |
| 04/18/2007 | EP1773328A1 Prebiotic intimate personal hygiene product |
| 04/18/2007 | EP1773327A1 Inhibitors of hsp90 |
| 04/18/2007 | EP1773326A2 Mitotic kinesin inhibitors |
| 04/18/2007 | EP1773325A1 Methods of using albuterol and calcium activated potassium channel openers |
| 04/18/2007 | EP1773324A1 Porphyrin derivatives and their use in photon activation therapy |
| 04/18/2007 | EP1773323A1 Progesterone receptor antagonist contraceptive regimens and kits |
| 04/18/2007 | EP1773322A1 Method for treating nervous system disorders and conditions |
| 04/18/2007 | EP1773321A2 Method for treating nervous system disorders and conditions |
| 04/18/2007 | EP1773320A1 Method for treating nervous system disorders and conditions |
| 04/18/2007 | EP1773319A1 Combinations of statins with bronchodilators |
| 04/18/2007 | EP1773318A1 Combination anticancer therapy and pharmaceutical compositions therefor |
| 04/18/2007 | EP1773317A2 Glycogen or polysaccharide storage disease treatment method |
| 04/18/2007 | EP1773316A1 Use of phenylethanolaminotetralines for preparing anxiolytic drugs |
| 04/18/2007 | EP1773315A1 Arylacetic acids and related compounds for treatment of alzheimer's disease |
| 04/18/2007 | EP1773314A2 Use of l-carnitine for the treatment of cardiovascular diseases |
| 04/18/2007 | EP1773313A2 Control of biofilm formation |
| 04/18/2007 | EP1773312A1 Composition containing statins and omega-3 fatty acids |
| 04/18/2007 | EP1773311A1 A gastric retained dosage form of gabapentin |
| 04/18/2007 | EP1773310A2 Alpha, beta-unsaturated sulfones, sulfoxides, sulfonimides, sulfinimides, acylsulfonamides and acylsulfinamides and therapeutic uses thereof |
| 04/18/2007 | EP1773309A1 Tamoxifen response in pre-and postmenopausal breast cancer patients |
| 04/18/2007 | EP1773308A1 Combination of bupropion and a second compound for affecting weight loss |
| 04/18/2007 | EP1773307A1 Compound formulations of 2-amino-1,3-propanediol compounds |
| 04/18/2007 | EP1773306A1 Medicament for the treatment of central nervous system disorders |
| 04/18/2007 | EP1773305A2 Method for treating skeletal disorders resulting from fgfr malfunction |
| 04/18/2007 | EP1773304A2 Method of treating ileus by pharmacological activation of cholinergic receptors |
| 04/18/2007 | EP1773301A2 Compositions comprising amphotericinb methods and systems |
| 04/18/2007 | EP1773300A2 Solid pharmaceutical composition comprising mirtazapine |
| 04/18/2007 | EP1773294A2 Compositions for delivering highly water soluble drugs |
| 04/18/2007 | EP1773290A1 Poly-gamma-glutamic acid-vitamin complex and use thereof |
| 04/18/2007 | EP1773128A2 Compositions and methods for the enhancement of chemotherapy with microbial cytotoxins |
| 04/18/2007 | EP1732572A4 Control of feeding behavior by changing neuronal energy balance |
| 04/18/2007 | EP1713490B1 Compositions for the treatment of atopic dermatitis, skin allergic conditions and acne |
| 04/18/2007 | EP1699468B1 Pharmaceutical composition comprising a zinc-hyaluronate complex for the treatment of multiple sclerosis |
| 04/18/2007 | EP1677777B1 Pellets containing venlafaxine hydrochloride |
| 04/18/2007 | EP1633369B1 Process to minimize loss through adhesion to equipment surfaces |
| 04/18/2007 | EP1592417B1 Combination of antidiabetic drugs |
| 04/18/2007 | EP1583531B1 Heteroaryl-substituted pyrrolo[2, 3- b]pyridine derivatives as crf receptor antagonists |
| 04/18/2007 | EP1581495B1 4-aryl-4-(naphth-1-ylmethylamino)methyl-piperidine compounds and their use |
| 04/18/2007 | EP1572190B1 Formulation comprising fenofibric acid, a physiologically acceptable salt or derivative thereof |
| 04/18/2007 | EP1567171B1 Use of dextran sulfate for treating ibmir |
| 04/18/2007 | EP1553949B1 Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors |
| 04/18/2007 | EP1545534B1 Use of 4-pyridylmethyl-phthalazine derivatives for the manufacture of a medicament for the treatment of myelodysplastic syndromes |
| 04/18/2007 | EP1542989B1 Protein tyrosine kinase inhibitors |
| 04/18/2007 | EP1537109B1 Novel benzonaphthyridines |
| 04/18/2007 | EP1536782B1 Synergistic combination of an alpha-2-delta ligand and a pdev inhibitor for use in the treatment of pain |
| 04/18/2007 | EP1514115B1 Diagnostic agent, method for detecting a carcinoma, and means for the treatment thereof |
| 04/18/2007 | EP1483243B1 Preparation of n1-(2'-pyridyl)-1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines |
| 04/18/2007 | EP1480636B1 Self emulsifying drug delivery systems for taxoids |
| 04/18/2007 | EP1476438B1 Oxa- and thiadiazoles and their use as metalloproteinase inhibitors |
| 04/18/2007 | EP1476162B1 Controlled synthesis of ziprasidone |
| 04/18/2007 | EP1458386B1 Aroyl pyrrole heteroeryl and methanols useful for treating a central nervous system disorder |
| 04/18/2007 | EP1455792B1 Ureas of 2-aminobenzothiazoles as adenosine modulators |
| 04/18/2007 | EP1453792B1 Amine 1,2- and 1,3-diol compounds and their use for treatment of alzheimer's disease |
| 04/18/2007 | EP1453545B1 Water-soluble polymer conjugates of retinoic acid |
| 04/18/2007 | EP1451161B1 Imidazopyridines, pyrimidines and triazines for enhancing cognition as gaba-a alpha 5 receptor subtype ligands |
| 04/18/2007 | EP1450823B1 Biocidal mixture of 2-propenal-releasing polymer and isothiazolones |
| 04/18/2007 | EP1442032B1 Heterocyclic retinoid compounds |
| 04/18/2007 | EP1436257B1 Low-calcemic oxime analogs of 1alpha, 25-dihydroxy vitamin d3 |
| 04/18/2007 | EP1435976B1 Pharmaceutical composition comprising chito-oligomers |
| 04/18/2007 | EP1429817B1 Porous ceramic composite bone grafts |
| 04/18/2007 | EP1406893B1 Pyrrolidine bicyclic compounds |
| 04/18/2007 | EP1401479B1 Detection and therapy of vulnerable plaque with photodynamic compounds |
| 04/18/2007 | EP1394161B1 L-ascorbic acid-2-o-maleic acid-a-tocopherol diester 1-propanol adduct and process for producing the same |
| 04/18/2007 | EP1393727B1 Remedial agent for myelopathic disease |
| 04/18/2007 | EP1392313B1 Combination comprising n- 5- 4-(4-methyl-piperazino-methyl)-benzoylamido|-2-methylphenyl -4-(3-pyridyl)-2pyrimidine-amine and a biphosphonate |
| 04/18/2007 | EP1390022B1 Use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno 2,3-d|pyrimidine for the treatment of pain |
| 04/18/2007 | EP1385526B1 3, 7 thia prostanoic acid derivatives as agents for lowering intraocular pressure |
| 04/18/2007 | EP1361264B1 PRODUCTS CONTAINING G(b)-GLUCAN |
| 04/18/2007 | EP1354590B1 Glucosamine or mannosamine in combination with trehalose against articular failure |
| 04/18/2007 | EP1353673B1 Camptothecin derivatives |
| 04/18/2007 | EP1353662B1 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors |
| 04/18/2007 | EP1345918B1 1,5 benzothiazepines and their use as antihyperlipidemics |
| 04/18/2007 | EP1335976B1 Modifier of organelle metalbolism |
| 04/18/2007 | EP1334194B1 Imaging, diagnosis and treatment of disease |
| 04/18/2007 | EP1326613B2 Use of substituted imidazo 1,2-a|pyridine-, imidazo ¬1,2-a|pyrimidine and imidazo ¬1,2-a|pyrazine-3-yl-amine derivatives for producing nos-inhibiting medicaments |
| 04/18/2007 | EP1313508B1 Combination containing an antifolate and methylmalonic acid lowering agent |
| 04/18/2007 | EP1305030B1 Use of 2-alpha-methyl-19-nor-20(s)-1-alpha,25-dihydroxyvitamin d3 in bone replacement |
| 04/18/2007 | EP1300405B1 Amino alcohol derivatives |
| 04/18/2007 | EP1276718B1 Small technetium-99m and rhenium labeled agents and methods for imaging tumors |
| 04/18/2007 | EP1240161B1 Thienylalanine derivatives as inhibitors of cell adhesion |
| 04/18/2007 | EP1227812B1 Topical nasal treatment using desloratadine and mometasone furoate |
| 04/18/2007 | EP1187846B1 11beta long-chain substituted estratrienes, method for their production, pharmaceutical preparations containing said 11beta long-chain substituted estratrienes, and their use for producing medicaments |
| 04/18/2007 | EP1186296B1 Mag expression promoters |
| 04/18/2007 | EP1144010B1 Prevention of chronic graft rejection by a combination of immunotoxins and costimulation blockers |
| 04/18/2007 | EP1137408B1 Agent for lowering endothelin levels |
| 04/18/2007 | EP1135160B1 Boron neutron capture therapy using pre-targeting methods |
| 04/18/2007 | EP1079843B1 Use of alfa1beta1 integrin receptor inhibitors and tgf- beta1 inhibitors in the treatment of kidney disease |